Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forIowa

Map
Iowa
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$38.3 million
to Iowa research institutions
450+ new jobs
for Iowa
Iowa

Neglected diseases in Iowa

Chikungunya cases
Chikungunya cases
11
Dengue cases
Dengue cases
30
HIV diagnoses
HIV diagnoses
1032
Malaria cases
Malaria cases
88
Tuberculosis cases
Tuberculosis cases
412
West Nile cases
West Nile cases
170
Zika cases
Zika cases
27
Iowa's top USG-funded global health R&D institutions

Iowa's top USG-funded global health R&D institutions

University of Iowa
$20.8 million
Iowa State University
$17.5 million
Iowa industry in global health R&D

Iowa industry in global health R&D

Integrated DNA Technologies
Location(s): Coralville
Newlink Genetics
Location(s): Ames

Iowa's top areas of global health R&D by USG funding

16.9%
HIV/AIDS
14.9%
Malaria
13.8%
Tuberculosis
10.5%
Salmonella infections
34.2%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
9.8%
Other
Bacterial pneumonia & meningitis
Ebola/viral hemorrhagic fevers
Non-allocable
Global health R&D at work in Iowa
Global health R&D at work in Iowa

Iowa State University researchers are looking for solutions to schistosomiasis, a devastating disease caused by parasitic worms. The worms can live for years in the human bloodstream, laying eggs that cause organ damage and impaired development in children. The disease is found in tropical areas, especially in poor communities without safe drinking water and adequate sanitation. More than 200 million people per year require treatment for schistosomiasis. Only one drug is currently available to fight the disease, but the parasites show signs of resistance. The Iowa team is examining the worm’s genome for vulnerability that could be targeted with new drug treatments. They’re also focusing on gene editing to make the worms sterile, thereby eliminating their ability to inflict damage.

Download PDF
Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: RTI Fights NTDS
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In